Events

We're excited to participate in the Alzheimer’s Association® International Conference (AAIC) 2024 from July 28 to July 31. Explore our latest technologies:True-to-Nature Drug/ Antibody FOPPR Characterization: Gain in-depth insights into molecular interactions with our advanced analysis, including drug structure and IVD antibody pair selection.Ultra Sensitivity FONLISA Detection: Experience exceptional performance with a compact design and unparalleled sensitivity, with a limit of detection (LOD) of ~fg/ml.

We are incredibly grateful to everyone who visited our booth at the BioAsia 2024 on July 26-29 . As Alzheimer's disease garners increasing attention, people are excited about how our groundbreaking technology can aid in the early detection of this condition. Additionally, we showcased our iNA Embedded NGS Precision Medicine System. This system enables in-house precision medicine, providing faster and more accurate diagnostic reports, and facilitating personalized health management and treatment plans. 

Excited to be invited to give a talk in the USA!By harnessing the capabilities of our ultra-sensitive, real-time immunoassay that operates within the range of pg/ml to fg/ml, we’re accelerating the pace of advancements in life sciences research, drug development, and precision healthcare. Our Light Sensing Biomarker Analyzer/Reader, developed on the foundation of our patented FOPPR (Fiber Optic Particle Plasmon Resonance) and IN-Chip (auto-flowing microfluidics chip) technology, sets a new benchmark for biomarker “Analysis” and “Detection”.Date & Time: 12:00pm - 1:00pm EDT Location: UF Innovate | Sid Martin BioTech, 12085 Research Dr, Alachua, FL 32615Lunch ProvidedRegister here: https://reurl.cc/qV7G3q

We are excited to share the significant strides we have made through our collaboration with ALZpath, presented at the Tau2024 Global Conference. This partnership marks a pivotal moment in advancing Alzheimer's research, leveraging our innovative Fiber Optic Particle Plasmon Resonance (FOPPR) technology to develop pTau-217 assay.

We were captivated by Madison Honey's remarkable lecture at the AD/PD 2024 Symposium. As a researcher from Prof. Charlotte Teunissen's Neurochemistry Lab at Amsterdam UMC, she presented a lecture titled "Development of a prototype point-of-care test using FOPPR technology for ultrasensitive detection of Neurofilament Light Chain in plasma."Madison demonstrated the use of Instant NanoBiosensors' FOPPR technology, covering everything from antibody selection and analysis to ultra-sensitive plasma testing. This is not only a paradigm of technological innovation but also brings new light to the diagnosis and research of neurodegenerative diseases. The potential of this technology will undoubtedly have a profound impact on our understanding and treatment of neurodegenerative diseases.Information on: https://adpd2024.kenes.com/The AD/PD Conference is a prestigious event where leading experts convene to delve into the newest research, clinical trials, and treatments for Alzheimer’s and Parkinson’s diseases. It offers a platform for revealing groundbreaking discoveries and discussing the latest advancements in therapies.The Conference offers a great opportunity to connect with and learn from top international experts, discuss the latest news and trends in the field, and present your work to receive valuable feedback.